Explore

Redox Signalling in physiology, ageing and disease

Redox Signalling in physiology, ageing and disease 2019

Newcastle, United Kingdom
1 - 3 July 2019
The conference ended on 03 July 2019

Important Dates

Abstract Submission Deadline
1st May 2019
Early Bird Deadline
1st May 2019

About Redox Signalling in physiology, ageing and disease

The goal of this meeting is to bring biochemists, cell and systems biologists investigating redox-signalling mechanisms in a variety of systems, together with those working on the biological mechanisms underlying ageing and age-associated diseases. As such this meeting with provide an interdisciplinary forum for discussion of new approaches to the study of redox regulation, the mechanisms involved, and the role of redox dysregulation in health, ageing and disease.

Topics

Mitochondria, Ageing, Metabolism, Signalling, Signaling, Aging, Reactive oxygen species, Health and disease, Antioxidants

Call for Papers

Oral communication slots are available at this meeting. All attendees, particularly researchers in the early stages of their career, are invited to submit a poster abstract for consideration as an oral communication.

Abstract Submission Guidelines The maximum number of words allowed in your abstract body is 230. 

Please type your abstract straight into the online submission form, or alternatively paste the text from a word-processed document. 

The ‘Full title’ should be presented sentence case (not in Title Case or BLOCK CAPITALS), that is only the first letter of the title or appropriate terms such as abbreviations or proper nouns should be upper case. 

Has my abstract been accepted? Approximately 2 weeks after the abstract submission deadline has passed, you will receive an email informing you whether your abstract has been accepted/rejected as an oral communication or poster. All abstracts will be available to view online.

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.